| Economic modeling of reSET-O, a prescription digital therapeutic for patients with opioid use disorder W Wang, N Gellings Lowe, A Jalali, SM Murphy Journal of Medical Economics 24 (1), 61-68, 2021 | 58 | 2021 |
| Economic modeling for the US of the cost-efficiency and associated expanded treatment access of conversion to biosimilar pegfilgrastim-bmez from reference pegfilgrastim A McBride, W Wang, K Campbell, S Balu, K MacDonald, I Abraham Journal of Medical Economics 23 (8), 856-863, 2020 | 24 | 2020 |
| Inhaled corticosteroid-containing treatment escalation and outcomes for patients with asthma in a US health care organization LGS Bengtson, Y Yu, W Wang, F Cao, EM Hulbert, R Wolbeck, CA Elliott, ... Journal of managed care & specialty pharmacy 23 (11), 1149-1159, 2017 | 23 | 2017 |
| Economic analysis on adoption of biosimilar granulocyte colony-stimulating factors in patients with nonmyeloid cancer at risk of febrile neutropenia within the oncology care … W Wang, E Li, K Campbell, A McBride, S D'Amato JCO Oncology Practice 17 (8), e1139-e1149, 2021 | 18 | 2021 |
| Association between betel quid chewing and carotid intima-media thickness in rural Bangladesh TR McClintock, F Parvez, F Wu, W Wang, T Islam, A Ahmed, I Shaheen, ... International journal of epidemiology 43 (4), 1174-1182, 2014 | 16 | 2014 |
| G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping review K Campbell, N Chadha, S Dimri, W Wang, E Li Expert Review of Hematology 15 (7), 619-633, 2022 | 10 | 2022 |
| Economic and clinical outcomes of pegfilgrastim via prefilled syringe vs on-body injector: a real-world data analysis A McBride, K Campbell, E Li, B Schroader, D Campbell, W Wang Journal of Managed Care & Specialty Pharmacy 27 (9), 1230-1238, 2021 | 8 | 2021 |
| The cost of cardiovascular-disease-related death in patients with type 2 diabetes mellitus S Shetty, D Stafkey-Mailey, B Yue, AD Coutinho, W Wang, A Del Parigi, ... Current Medical Research and Opinion 34 (6), 1081-1087, 2018 | 6 | 2018 |
| The impact of baseline risk factors on the incidence of febrile neutropenia in breast cancer patients receiving chemotherapy with pegfilgrastim prophylaxis: A real-world data … E Li, BK Schroader, D Campbell, K Campbell, W Wang Journal of Health Economics and Outcomes Research 8 (1), 106, 2021 | 3 | 2021 |
| Minimally invasive procedures for right side infective endocarditis: A targeted literature review W Wang, S Itagaki, N Egorova Catheterization and Cardiovascular Interventions 103 (6), 1050-1061, 2024 | 1 | 2024 |
| HSR21-073: Febrile Neutropenia Outcomes Among Patients With Breast Cancer and Non-Hodgkin’s Lymphoma Receiving Pegfilgrastim Prophylaxis: A Real-World Analysis of Commercial … W Wang, E Li, K Campbell, A McBride Journal of the National Comprehensive Cancer Network 19 (3.5), HSR21-073 …, 2021 | 1 | 2021 |
| Incremental burden of type 2 diabetes mellitus in patients hospitalized for heart failure AD Raju, AD Coutinho, W Wang, S Shetty, SS Sander, CI Coleman Endocrine Practice 22, 20, 2016 | 1 | 2016 |
| Economic burden of type 2 diabetes mellitus in patients with cardiovascular disease in commercially-insured patients in the United States W Wang, EM Farrelly, S Shetty, D Stafkey-Mailey, SD Sander, CI Coleman Endocrine Practice 22, 21, 2016 | 1 | 2016 |
| WCN23-0369 SYMPTOM BURDEN OF PATIENTS WITH IgA NEPHROPATHY IN A REAL WORLD SETTING ACROSS GEOGRAPHIES R Lafayette, S Smeets, J Kattlun, AT George, C Aldworth, C Proudfoot, ... Kidney International Reports 8 (3), S257-S258, 2023 | | 2023 |
| WCN23-0625 THE PATIENT JOURNEY FOR IMMUNOGLOBULIN A NEPHROPATHY: DIAGNOSTIC DELAY AND CHANGE IN KIDNEY FUNCTION FROM FIRST CLINICAL SIGN R Perkins, E Swallow, W Wang, E Gao, S Olson, J Sung, H Nguyen, ... Kidney International Reports 8 (3), S121, 2023 | | 2023 |
| WCN23-0383 PERSISTENCE OF SIGNS AND SYMPTOMS IN TREATED PATIENTS WITH IgAN: EVIDENCE FROM REAL-WORLD DATA R Lafayette, M Kroes, C Aldworth, LP Rodriguez, AT George, W Wang, ... Kidney International Reports 8 (3), S258, 2023 | | 2023 |
| A Budget Impact Analysis on the Prophylactic Use of Biosimilar Pegfilgrastim-bmez in Non-myeloid Cancer Patients at Risk of Chemotherapy-induced Febrile Neutropenia and Its … W Wang, E Li, K Campbell, D Ribes Resource 50 (2024), 60, 2023 | | 2023 |
| POS-050 THE PATIENT JOURNEY FOR IMMUNOGLOBULIN A NEPHROPATHY: DIAGNOSTIC DELAY AND CHANGE IN KIDNEY FUNCTION FROM FIRST CLINICAL SIGN R Perkins, E Swallow, W Wang, E Gao, S Olson, J Sung, H Nguyen, ... Kidney International Reports 7 (6), S459-S460, 2022 | | 2022 |
| Real-world Signs and Symptoms at Diagnosis in Patients with IgA Nephropathy D Roccatello, J Kattlun, R Przybysz, A George, C Aldworth, C Proudfoot, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 37, I159-I160, 2022 | | 2022 |
| Population-based identification of biopsy-proven IgA nephropathy using natural language processing: The KNIGHT Study RV Parikh, TC Tan, A Mahapatra, W Wang, R Perkins, AS Go Heart failure 26, 1.5, 2022 | | 2022 |
Edward Li, PharmD, MPH, BCOP在 une.edu 的电子邮件经过验证
Edward Li, PharmD, MPH, BCOP在 une.edu 的电子邮件经过验证
Yu ChenNYU Grossman School of Medicine, NYU在 nyulangone.org 的电子邮件经过验证
Craig I. ColemanUniversity of Connecticut在 harthosp.org 的电子邮件经过验证